US FDA Formalizes ‘One-Trial’ Approach For Oncology Accelerated Approval

 
• By Derrick Gingery
Neurology lab
OCE guidance says one or two randomized controlled trials could be sufficient to receive accelerated approval and confirm clinical benefit. • Source: Shutterstock

More from R&D

More from Pink Sheet